FSA Advisors Inc. Takes $28.06 Million Position in Intuitive Surgical, Inc. $ISRG

Key Points

• FSA Advisors purchased a new Q4 stake of 49,549 shares in Intuitive Surgical valued at about $28.06 million, making ISRG roughly 4.9% of FSA's holdings and its third-largest position.
• Intuitive reported a strong quarter (April 21) with $2.50 EPS vs. $2.08 expected and revenue of $2.77 billion (up 23% YoY); the company has a market cap near $162.1 billion and a P/E around 55.5.
• Institutional ownership is high (~83.6%), analysts are broadly positive (consensus "Moderate Buy" with an average price target of $581.91), though company insiders have recently sold shares.

FSA Advisors Inc. bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 49,549 shares of the medical equipment provider's stock, valued at approximately $28,063,000. Intuitive Surgical accounts for about 4.9% of FSA Advisors Inc.'s holdings, making the stock its 3rd largest holding.

Several other hedge funds have also recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in shares of Intuitive Surgical by 0.8% during the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider's stock valued at $15,026,776,000 after buying an additional 263,828 shares during the period. Capital World Investors increased its stake in shares of Intuitive Surgical by 1.5% during the third quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider's stock valued at $3,456,223,000 after buying an additional 116,034 shares during the period. Fisher Asset Management LLC boosted its position in shares of Intuitive Surgical by 1.1% during the third quarter. Fisher Asset Management LLC now owns 3,889,439 shares of the medical equipment provider's stock valued at $1,739,475,000 after purchasing an additional 40,702 shares in the last quarter. Amundi grew its stake in Intuitive Surgical by 29.7% in the third quarter. Amundi now owns 3,227,472 shares of the medical equipment provider's stock worth $1,451,362,000 after purchasing an additional 739,444 shares during the period. Finally, Jennison Associates LLC grew its stake in Intuitive Surgical by 11.1% in the fourth quarter. Jennison Associates LLC now owns 3,209,137 shares of the medical equipment provider's stock worth $1,817,527,000 after purchasing an additional 321,759 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $457.78 on Monday. The business's fifty day simple moving average is $474.86 and its two-hundred day simple moving average is $517.11. Intuitive Surgical, Inc. has a 12 month low of $427.84 and a 12 month high of $603.88. The company has a market capitalization of $162.13 billion, a price-to-earnings ratio of 55.49, a price-to-earnings-growth ratio of 3.66 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same period in the previous year, the company posted $1.81 earnings per share. The company's revenue for the quarter was up 23.0% compared to the same quarter last year. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Mark Brosius sold 645 shares of the business's stock in a transaction on Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the sale, the senior vice president directly owned 1,613 shares of the company's stock, valued at approximately $782,321.13. The trade was a 28.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Myriam Curet sold 105 shares of the business's stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total value of $51,864.75. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 5,906 shares of company stock valued at $2,907,726. Company insiders own 0.60% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on ISRG shares. Wall Street Zen cut Intuitive Surgical from a "buy" rating to a "hold" rating in a research note on Saturday, February 7th. Barclays set a $651.00 price target on Intuitive Surgical and gave the stock an "overweight" rating in a research note on Thursday, April 23rd. Sanford C. Bernstein upped their price target on Intuitive Surgical from $740.00 to $750.00 and gave the stock an "outperform" rating in a research note on Friday, January 23rd. Truist Financial reduced their price target on Intuitive Surgical from $650.00 to $580.00 and set a "buy" rating on the stock in a research note on Wednesday, April 15th. Finally, Piper Sandler reduced their price target on Intuitive Surgical from $620.00 to $580.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 22nd. Eighteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average price target of $581.91.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.